Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy

Cancer is the second leading cause of death worldwide, with 10.0 million cancer deaths in 2020. Despite advances in targeted therapies, some pharmacological drawbacks associated with anticancer chemo and immunotherapeutic agents include high toxicities, low bioavailability, and drug resistance. In r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanmartin, María Cecilia, Borzone, Francisco Raúl, Giorello, María Belén, Yannarelli, Gustavo, Chasseing, Norma Alejandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046597/
https://www.ncbi.nlm.nih.gov/pubmed/35497332
http://dx.doi.org/10.3389/fbioe.2022.882545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046597/
https://www.ncbi.nlm.nih.gov/pubmed/35497332
http://dx.doi.org/10.3389/fbioe.2022.882545

Ejemplares similares